In 2020, Nick took on the role of interim CEO of ViralClear to help in the development of a COVID-19 treatment. Over his 40-year career, he has held leadership positions with Merck and Merial, among many others. Nick was also the founder, chairman, and CEO of Topaz Pharmaceuticals and the founder and managing partner of Humanitas Consulting. Nick is a highly experienced, results-oriented executive with a strong track record of team building, strategic planning, and tactical execution in pharma, biotech, and medical device organizations.
OTHER MANAGEMENT MEMBERS
